Veritable, L.P. Vertex Pharmaceuticals Inc Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $40,874 - $45,748	-130 Reduced 1.77%	7,205 $2.54 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $41,634 - $47,495	147 Added 2.05%	7,335 $2.31 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $56,294 - $63,331	197 Added 2.82%	7,188 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $2,464 - $2,749	9 Added 0.13%	6,991 $2.02 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $90,224 - $112,339	384 Added 5.82%	6,982 $1.97 Million
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $38,305 - $45,147	173 Added 2.69%	6,598 $1.72 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $56,112 - $70,833	-317 Reduced 4.7%	6,425 $1.41 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $22,673 - $25,373	-125 Reduced 1.82%	6,742 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $9,561 - $11,276	51 Added 0.75%	6,867 $1.39 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $145,328 - $169,399	702 Added 11.48%	6,816 $1.47 Million
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $102,469 - $136,664	-495 Reduced 7.49%	6,114 $1.45 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $11,248 - $13,336	-44 Reduced 0.66%	6,609 $1.8 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $146,111 - $191,678	-648 Reduced 8.88%	6,653 $1.93 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $6,192 - $7,682	-31 Reduced 0.42%	7,301 $1.74 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $23,839 - $32,019	143 Added 1.99%	7,332 $1.61 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $12,633 - $14,218	76 Added 1.07%	7,189 $1.22 Million
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $9,876 - $11,422	-60 Reduced 0.84%	7,113 $1.3 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $29,962 - $35,630	183 Added 2.62%	7,173 $1.32 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $46,028 - $58,239	-303 Reduced 4.15%	6,990 $1.16 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $69,104 - $79,408	412 Added 5.99%	7,293 $1.41 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $66,302 - $77,331	455 Added 7.08%	6,881 $1.17 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $50,028 - $58,452	330 Added 5.41%	6,426 $1.05 Million
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $38,438 - $43,554	-280 Reduced 4.39%	6,096 $914,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $944,476 - $1.03 Million	6,376	6,376 $969,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account